ArticleThoracic cancer2019

The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer.

Ja Yoon Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.